Merck & Co Inc
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans. President Joe Biden’s Inflation Reduction Act, which passed in a […]
Read More
Why startups are investing thousands and thousands to make prescription drugs and semiconductors in house
In-area producing may audio like science fiction but it is going on previously, albeit on a very modest scale. It is really a fledgling market place that analysts and numerous startups are projecting will get off. “If you appear at pharma, semiconductors, splendor and health items and potentially foodstuff in the sense of like new […]
Read More
These 10 medications are likely targets for Medicare price negotiations this fall
Merck & Co. Inc. Januvia brand medication, used to treat type2 diabetes, sit on a pharmacy shelf in Princeton, Illinois. Daniel Acker | Bloomberg | Getty Images Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade history. The Centers for Medicare […]
Read More
Goldman Sachs names ‘directors’ cut’ conviction record stocks — and adds 2 names
Goldman Sachs highlighted a slew of stocks on its U.S. “conviction checklist — director’s slice” variety, naming many “most differentiated get suggestions,” in an August 1 exploration take note. Goldman’s “directors’ slice” is a checklist of stocks chosen by its U.S. exploration analysts and supervisors. The lender collated a checklist of “top rated tips that […]
Read More
Stocks creating the biggest moves premarket: Uber, Gap, Caterpillar & much more
People stroll by a Gap retail shop on August 24, 2022 in Beijing, China. VCG | Getty Pictures Verify out the businesses producing headlines in advance of the bell on Tuesday. SoFi Systems — The money engineering stock dropped 3.7% just after KBW analyst Michael Perito downgraded the stock from underperform from sector carry out. […]
Read More
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a quarterly loss, however, due to charges associated with the company’s acquisition of Prometheus Biosciences earlier this year. related investing news Merck swung to a net loss of $5.98 […]
Read More
Inventory futures are minimal adjusted as Wall Street’s busiest earnings 7 days carries on: Stay updates
Traders operate on the floor of the New York Inventory Exchange, July 12, 2023. Spencer Platt | Getty Visuals U.S. stock futures traded close to the flat line Monday night as traders await a flood of company earnings stories. Dow Jones Industrial Ordinary futures rose by 12 points, or .03%. Futures joined to the S&P […]
Read More
Earnings playbook: How to trade some of the greatest reports this week, including Apple
This could be a make-or-break 7 days for next-quarter earnings year. When all is mentioned and accomplished, about 160 S & P 500 businesses will have claimed their latest quarterly outcomes — making this the busiest 7 days of the overall reporting interval. By Monday’s open, more than 250 names experienced previously documented, with 81% […]
Read More
A.I. could mean a ‘decade of health care is upon us.’ Here are some stock picks
Investors hoping to capture more upside from artificial intelligence could turn to a sector that’s underperformed this year, and maybe not immediately associated with AI: Health care. A handful of large tech names surged in the first half thanks to a mania for all things tied to artificial intelligence. Apple, for example, last week closed […]
Read More
Moderna strikes deal to develop mRNA drugs in China
Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop drugs […]
Read More